98 related articles for article (PubMed ID: 18644999)
1. Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth.
Qiu XC; Xu YM; Wang F; Fan QY; Wang LF; Ma BA; Jia LT; Zhao J; Meng YL; Yao LB; Chen SY; Yang AG
Mol Cancer Ther; 2008 Jul; 7(7):1890-9. PubMed ID: 18644999
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant immuno-tBid with a furin site effectively suppresses the growth of HER2-positive osteosarcoma cells in vitro.
Shan LQ; Ma S; Qiu XC; Wang T; Yu SB; Ma BA; Zhou Y; Fan QY; Yang AG
Oncol Rep; 2011 Feb; 25(2):325-31. PubMed ID: 21152867
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
[TBL] [Abstract][Full Text] [Related]
4. scFv-mediated delivery of truncated BID suppresses HER2-positive osteosarcoma growth and metastasis.
Shan LQ; Qiu XC; Xu YM; Ji ZG; Yang TT; Chen X; Ma BA; Zhou Y; Fan QY; Yang AG
Cancer Biol Ther; 2008 Nov; 7(11):1717-22. PubMed ID: 18787415
[TBL] [Abstract][Full Text] [Related]
5. A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma.
Zhou BG; Liu MY; Qiu XC; Xu YM; Fan QY; Yang AG; Zhang Y; Xia H
Oncol Rep; 2013 Jan; 29(1):276-82. PubMed ID: 23135254
[TBL] [Abstract][Full Text] [Related]
6. A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors.
Xu YM; Wang LF; Jia LT; Qiu XC; Zhao J; Yu CJ; Zhang R; Zhu F; Wang CJ; Jin BQ; Chen SY; Yang AG
J Immunol; 2004 Jul; 173(1):61-7. PubMed ID: 15210759
[TBL] [Abstract][Full Text] [Related]
7. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
[TBL] [Abstract][Full Text] [Related]
8. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
9. Potent killing of HBV-related hepatocellular carcinoma by a chimeric protein of anti-HBsAg single-chain antibody and truncated Bid.
Yan B; Ouyang Q; Zhao Z; Cao F; Wang T; Jia X; Meng Y; Jiang S; Liu J; Chen R; Jia L; Zhang R; Wen W; Jin B; Chen S; Zhao J; Yang A
Biomaterials; 2013 Jul; 34(20):4880-9. PubMed ID: 23562050
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein.
Zhang DX; Zhao PT; Xia L; Liu LL; Liang J; Zhai HH; Zhang HB; Guo XG; Wu KC; Xu YM; Jia LT; Yang AG; Chen SY; Fan DM
Gut; 2010 Mar; 59(3):292-9. PubMed ID: 19951902
[TBL] [Abstract][Full Text] [Related]
11. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production.
Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM
Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620
[TBL] [Abstract][Full Text] [Related]
12. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
[TBL] [Abstract][Full Text] [Related]
13. Selective proapoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2.
Yu CJ; Jia LT; Meng YL; Zhao J; Zhang Y; Qiu XC; Xu YM; Wen WH; Yao LB; Fan DM; Jin BQ; Chen SY; Yang AG
Gene Ther; 2006 Feb; 13(4):313-20. PubMed ID: 16267568
[TBL] [Abstract][Full Text] [Related]
14. Secreted antibody/granzyme B fusion protein stimulates selective killing of HER2-overexpressing tumor cells.
Zhao J; Zhang LH; Jia LT; Zhang L; Xu YM; Wang Z; Yu CJ; Peng WD; Wen WH; Wang CJ; Chen SY; Yang AG
J Biol Chem; 2004 May; 279(20):21343-8. PubMed ID: 15004021
[TBL] [Abstract][Full Text] [Related]
15. Construction of humanized anti-HER2 single-chain variable fragments (husFvs) and achievement of potent tumor suppression with the reconstituted husFv-Fdt-tBid immunoapoptotin.
Ou-Yang Q; Yan B; Li A; Hu ZS; Feng JN; Lun XX; Zhang MM; Zhang MD; Wu KC; Xue FF; Yang AG; Zhao J
Biomaterials; 2018 Sep; 178():170-182. PubMed ID: 29935385
[TBL] [Abstract][Full Text] [Related]
16. Induction of programmed cell death in ErbB2/HER2-expressing cancer cells by targeted delivery of apoptosis-inducing factor.
Mahmud H; Dälken B; Wels WS
Mol Cancer Ther; 2009 Jun; 8(6):1526-35. PubMed ID: 19509241
[TBL] [Abstract][Full Text] [Related]
17. Real time single cell analysis of Bid cleavage and Bid translocation during caspase-dependent and neuronal caspase-independent apoptosis.
Ward MW; Rehm M; Duessmann H; Kacmar S; Concannon CG; Prehn JH
J Biol Chem; 2006 Mar; 281(9):5837-44. PubMed ID: 16407197
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
19. Truncated Bid Regulates Cisplatin Response via Activation of Mitochondrial Apoptosis Pathway in Ovarian Cancer.
Dai Y; Zhao XJ; Li F; Yuan Y; Yan DM; Cao H; Huang XY; Hu Z; Ma D; Gao QL
Hum Gene Ther; 2020 Mar; 31(5-6):325-338. PubMed ID: 32024383
[TBL] [Abstract][Full Text] [Related]
20. Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells.
Cai Y; Xi Y; Cao Z; Xiang G; Ni Q; Zhang R; Chang J; Du X; Yang A; Yan B; Zhao J
Cancer Lett; 2016 Oct; 381(1):104-12. PubMed ID: 27473824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
